| Drew Michael Taylor, MD | |
|
3773 E Cherry Creek North Dr Ste 970, Denver, CO 80209-9809 | |
| (303) 388-5629 | |
| Not Available |
| Full Name | Drew Michael Taylor |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 12 Years |
| Location | 3773 E Cherry Creek North Dr Ste 970, Denver, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003173154 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | DR.0058044 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Valley View Hospital Association | Glenwood springs, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bella Derma, Llc | 2466424072 | 12 |
News Archive
The interconnections and communication between different regions of the human brain influence our behavior in many ways.
Astellas Pharma Europe Ltd., the European Headquarters of Tokyo-based Astellas Pharma Inc. (TSE:4503), and Medivation, Inc. announced that following the regulatory review process by the European Medicines Agency (EMA) and a positive opinion from the Committee for Medicinal Products for Human Use on April 25, 2013, the European Commission (EC) has granted the marketing authorization for XTANDI™ (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy.
Prof. Jiunn-Der Liao of Department of Materials Science and Engineering at National Cheng Kung University (NCKU), Tainan, Taiwan, has led Post Doctorate Chih-Chiang Weng and a research team to develop a pen-size plasma sterilization device which can sterilize instruments and wounds by relying on the process of plasma sterilization.
Up to 6 years after receiving a single treatment with the gene therapy product lipoprotein lipase (LPL), patients with the debilitating genetic disease LPL deficiency (LPLD) had about 50% fewer episodes of pancreatitis than before receiving the treatment.
When transplant clinics must publicly report their success rates, this should provide an incentive to improve care for patients. But a recent study appearing in the Clinical Journal of the American Society Nephrology (CJASN) found that such public reporting has not had any effect on the care that transplant patients receive.
› Verified 1 days ago
| Entity Name | Bella Derma, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730106642 PECOS PAC ID: 2466424072 Enrollment ID: O20040812000579 |
News Archive
The interconnections and communication between different regions of the human brain influence our behavior in many ways.
Astellas Pharma Europe Ltd., the European Headquarters of Tokyo-based Astellas Pharma Inc. (TSE:4503), and Medivation, Inc. announced that following the regulatory review process by the European Medicines Agency (EMA) and a positive opinion from the Committee for Medicinal Products for Human Use on April 25, 2013, the European Commission (EC) has granted the marketing authorization for XTANDI™ (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy.
Prof. Jiunn-Der Liao of Department of Materials Science and Engineering at National Cheng Kung University (NCKU), Tainan, Taiwan, has led Post Doctorate Chih-Chiang Weng and a research team to develop a pen-size plasma sterilization device which can sterilize instruments and wounds by relying on the process of plasma sterilization.
Up to 6 years after receiving a single treatment with the gene therapy product lipoprotein lipase (LPL), patients with the debilitating genetic disease LPL deficiency (LPLD) had about 50% fewer episodes of pancreatitis than before receiving the treatment.
When transplant clinics must publicly report their success rates, this should provide an incentive to improve care for patients. But a recent study appearing in the Clinical Journal of the American Society Nephrology (CJASN) found that such public reporting has not had any effect on the care that transplant patients receive.
› Verified 1 days ago
| Entity Name | Epiphany Dermatology Of Colorado Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992297469 PECOS PAC ID: 8921354341 Enrollment ID: O20180627001525 |
News Archive
The interconnections and communication between different regions of the human brain influence our behavior in many ways.
Astellas Pharma Europe Ltd., the European Headquarters of Tokyo-based Astellas Pharma Inc. (TSE:4503), and Medivation, Inc. announced that following the regulatory review process by the European Medicines Agency (EMA) and a positive opinion from the Committee for Medicinal Products for Human Use on April 25, 2013, the European Commission (EC) has granted the marketing authorization for XTANDI™ (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy.
Prof. Jiunn-Der Liao of Department of Materials Science and Engineering at National Cheng Kung University (NCKU), Tainan, Taiwan, has led Post Doctorate Chih-Chiang Weng and a research team to develop a pen-size plasma sterilization device which can sterilize instruments and wounds by relying on the process of plasma sterilization.
Up to 6 years after receiving a single treatment with the gene therapy product lipoprotein lipase (LPL), patients with the debilitating genetic disease LPL deficiency (LPLD) had about 50% fewer episodes of pancreatitis than before receiving the treatment.
When transplant clinics must publicly report their success rates, this should provide an incentive to improve care for patients. But a recent study appearing in the Clinical Journal of the American Society Nephrology (CJASN) found that such public reporting has not had any effect on the care that transplant patients receive.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Drew Michael Taylor, MD 7300 Ranch Road 2222, Building 1, Ste 200, Austin, TX 78730 Ph: (512) 628-0465 | Drew Michael Taylor, MD 3773 E Cherry Creek North Dr Ste 970, Denver, CO 80209-9809 Ph: (303) 388-5629 |
News Archive
The interconnections and communication between different regions of the human brain influence our behavior in many ways.
Astellas Pharma Europe Ltd., the European Headquarters of Tokyo-based Astellas Pharma Inc. (TSE:4503), and Medivation, Inc. announced that following the regulatory review process by the European Medicines Agency (EMA) and a positive opinion from the Committee for Medicinal Products for Human Use on April 25, 2013, the European Commission (EC) has granted the marketing authorization for XTANDI™ (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer whose disease has progressed on or after docetaxel therapy.
Prof. Jiunn-Der Liao of Department of Materials Science and Engineering at National Cheng Kung University (NCKU), Tainan, Taiwan, has led Post Doctorate Chih-Chiang Weng and a research team to develop a pen-size plasma sterilization device which can sterilize instruments and wounds by relying on the process of plasma sterilization.
Up to 6 years after receiving a single treatment with the gene therapy product lipoprotein lipase (LPL), patients with the debilitating genetic disease LPL deficiency (LPLD) had about 50% fewer episodes of pancreatitis than before receiving the treatment.
When transplant clinics must publicly report their success rates, this should provide an incentive to improve care for patients. But a recent study appearing in the Clinical Journal of the American Society Nephrology (CJASN) found that such public reporting has not had any effect on the care that transplant patients receive.
› Verified 1 days ago
Dr. William J Bowman, MD Dermatology Medicare: Medicare Enrolled Practice Location: 3464 S Willow St, Suite 194, Denver, CO 80231 Phone: 303-755-2900 Fax: 303-745-7997 | |
Samantha J Lewis, CRNP Dermatology Medicare: Accepting Medicare Assignments Practice Location: 777 Bannock St, Denver, CO 80204 Phone: 303-602-6196 | |
Dr. Patricia A Sinoway, MD Dermatology Medicare: Medicare Enrolled Practice Location: 10350 E Dakota Ave, Denver, CO 80247 Phone: 303-338-4545 | |
Dr. Elisa Suzanne Kapler, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2045 N Franklin St, Denver, CO 80205 Phone: 303-338-4545 | |
Dr. Brian Woodford Petersen, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1375 E 20th Ave, Denver, CO 80205 Phone: 303-338-4545 | |
Dr. Neil J Silverman, MD Dermatology Medicare: Medicare Enrolled Practice Location: 10350 E Dakota Ave, Denver, CO 80247 Phone: 303-338-4545 |